Scientists have made a breakthrough that could lead to effective treatments for lymphedema, a painful swelling condition for ...

And the presence of the Barcelona Science Park, which is the first science park in Spain that is home to three research institutes and more than 70 companies, make the city a viable location for ...

A new discovery involving the larva of zebrafish shows promise for treating or preventing painful lymphoedema.

Learn more about whether IDEAYA Biosciences, Inc. or Viridian Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 February 11, 2026 6:30 ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST My name is Julianne, and I will be your conference facilitator today for the Amgen Q4 2025 Earnings Conference Call. [Operator ...

A new white paper issued by the Clayman Thyroid Center in Tampa, Florida, concludes that popular GLP-1 receptor agonists ...

Patients using GLP-1 agonists had a significantly lower hysterectomy rate over 2-year and 5-year follow-up. Women with nonmalignant uterine disease and a history of GLP-1 agonist and progestin ...

Adults with differentiated thyroid cancer who are using a GLP-1 for the treatment of diabetes or obesity do not have increased risk for cancer recurrence or progression vs. those not using a GLP-1, ...

Researchers at UCLA have found a way to supercharge immune cells with a fuel source that tumors can't steal, dramatically ...

Despite their renal and cardiovascular protection, GLP-1RA vs SGLT2i carries somewhat higher risks of renal cell carcinoma and urothelial cell carcinoma in adults with type 2 diabetes. The risks of ...